Indian Journal of Endocrinology and Metabolism

ORIGINAL ARTICLE
Year
: 2011  |  Volume : 15  |  Issue : 2  |  Page : 110--114

Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy


Fakhir S Al-Ani1, Marwan S Al-Nimer2, Fatima S Ali3 
1 Department of Physiology, College of Medicine, Al-Nahrin University, Baghdad, Iraq
2 Department of Pharmacology, College of Medicine, Al-Mustansiriya University, Baghdad, Iraq
3 Department of Neurosurgery, Khoula hospital, Minaa Al-Fahal, Muscat, Oman

Correspondence Address:
Marwan S Al-Nimer
Department of Pharmacology, College of Medicine, Al-Mustansiriya University, P.O. Box 14132, Baghdad
Iraq

Objectives: The pathogenesis of neuropathy in type 2 diabetes mellitus is multifactorial.Dyslipidemia may contribute to the development of diabetic neuropathy. This study aimed to assess the atherogenic lipid indices in type 2 diabetic patients with neuropathy.Material and Methods: Fifty-one patients with type 2 diabetes mellitus and 31 healthy subjects were studied in the Unit of Neurophysiology at the University Hospital of Medical College, Al-Nahrin University in Baghdad, Iraq, from January 2002 to January 2003. Neuropathy total symptom score (NTSS), neuropathy impairment score in the lower leg (NIS-LL), and electrophysiological study of sensory (ulnar and sural) and motor (ulnar and common peroneal) nerves were used to assess nerve function. Fasting venous blood was obtained from each participant for determination of lipid profile and atherogenic lipid ratios. Results: The frequency of high blood pressure was significantly higher in neuropathic patients. The electrophysiology study revealed significant decrease in conduction velocity of ulnar (sensory and motor components), sural, and common peroneal nerves. The minimum F-wave latency of motor nerve was significantly prolonged. Among the lipid fractions, only high-density lipoprotein-cholesterol was significantly reduced by 14% of healthy participant«SQ»s value. Atherogenic lipid ratios were significantly higher in diabetic patients than corresponding healthy ratios. Conclusion: Metabolic lipid disturbances in terms of atherogenicity co-existwith neuropathy in type 2 diabetes mellitus, irrespective of duration of disease.


How to cite this article:
Al-Ani FS, Al-Nimer MS, Ali FS. Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy.Indian J Endocr Metab 2011;15:110-114


How to cite this URL:
Al-Ani FS, Al-Nimer MS, Ali FS. Dyslipidemia as a contributory factor in etiopathogenesis of diabetic neuropathy. Indian J Endocr Metab [serial online] 2011 [cited 2020 Apr 6 ];15:110-114
Available from: http://www.ijem.in/article.asp?issn=2230-8210;year=2011;volume=15;issue=2;spage=110;epage=114;aulast=Al-Ani;type=0